Nguyen, Minhtri K., and Ira Kurtz. New insights into the pathophysiology of the dysnatremias: a quantitative analysis. Am J Physiol Renal Physiol 287: F172-F180, 2004; 10.1152/ajprenal.00106.2004.-Recent theoretical considerations have played an important role in advancing our understanding of the physiological mechanisms responsible for perturbing the plasma water sodium concentration ([Na ϩ ]pw) in health and disease. Central to these considerations is the original empirical relationship between the [Na ϩ ]pw and total exchangeable sodium (Nae), total exchangeable potassium (K e), and total body water (TBW) initially discovered by Edelman and colleagues (Edelman IS, Leibman J, O'Meara MP, and Birkenfeld LW. J Clin Invest 37: 1236 -1256, 1958). The non-zero values of the slope and y-intercept in the Edelman equation are a consequence of the effects of the osmotic coefficient of Na ϩ salts at physiological concentrations and Gibbs-Donnan and osmotic equilibrium. Moreover, in addition to Na e, Ke, and TBW, the physiological components of the y-intercept in this equation play a role in modulating the [Na ϩ ]pw and in the generation of the dysnatremias. In this review, the pathophysiological mechanisms underlying the generation and treatment of the dysnatremias are analyzed theoretically and quantitatively. Importantly, the non-zero values of both the slope and y-intercept in the Edelman equation result in several theoretical predictions that can be tested experimentally and have been mathematically incorporated into recently derived equations used to analyze both the generation and the optimal treatment of the dysnatremias. In addition, we review current concepts regarding 1) the role of Gibbs-Donnan and osmotic equilibrium in the determination of the [Na ϩ ]pw; 2) the modulating effect of osmotically inactive exchangeable Na ϩ and K ϩ on the [Na ϩ ]pw; 3) the effect of glucose on the [Na ϩ ]pw as reflected by changes in Nae, Ke, and TBW as well as changes in several components of the y-intercept resulting from the hyperglycemia; and 4) the complex role of K ϩ in modulating the [Na ϩ ]pw.
The slope and y-intercept in the Edelman equation have recently been shown to have quantitative and physiological significance (27, 28) . This analysis demonstrates that there are several physiologically relevant parameters determining the magnitude of the slope and y-intercept that independently alter the [Na 
where G ϭ ͑V pw ϩ V ISF ͒ V pw ϩ 0.95 ϫ V ISF Ø ϭ average osmotic coefficient of Na ϩ salts; 0.95 ϭ Gibbs-Donnan ratio for the distribution of univalent cations between the plasma and interstitial fluid; G ϭ Gibbs-Donnan effect;V pw ϭ plasma water volume; V ISF ϭ interstitial fluid volume; Na osm inactive ϭ osmotically inactive Na ϩ ; K osm inactive ϭ osmotically inactive K ϩ ; osmol ECF ϭ osmotically active, extracellular non-Na ϩ and non-K ϩ osmoles; osmol ICF ϭ osmotically active, intracellular non-Na ϩ and non-K ϩ osmoles; [Na ϩ ] pw ϭ plasma water Na ϩ concentration; [K ϩ ] pw ϭ plasma water K ϩ concentration; and osmol pw ϭ osmotically active, plasma water non-Na ϩ non-K ϩ osmoles.
DETERMINANTS OF THE SLOPE IN THE EDELMAN EQUATION
The slope of the Edelman equation is represented by the term G/Ø and is a reflection of the osmotic coefficient (Ø) and the Gibbs-Donnan effect (G) on the [Na ϩ ] pw ( Fig. 2 ) (28) . It is known that the body fluid compartments are in osmotic equilibrium and that TBW is passively distributed in proportion to osmotic activity. Because each mole of ionic particle does not exert exactly one osmole of osmotic activity due to the electrical interactions between the ions (i.e., the osmotic activity of most ionic particles is slightly Ͻ1), the osmotic coefficient Ø in the slope accounts for the effectiveness of Na ϩ salts as independent osmotically active particles under physiological conditions (22, 28) . Additionally, the term G in the slope is a reflection of the effect of Gibbs-Donnan equilibrium on the [Na ϩ ] pw . Due to the presence of negatively charged, impermeant proteins in the plasma space, the distribution of Na ϩ and its associated anions is altered to preserve electroneutrality in the plasma and interstitial fluid compartments (17, 30 . Second, the term G is also a function of the volumes of the plasma and interstitial fluid (V pw and V ISF ) because the distribution of Na ϩ ions between the plasma and interstitial fluid (ISF) at equilibrium will depend on the respective volumes of the plasma and ISF. In other words, there will be more Na ϩ ions distributed in the ISF at equilibrium than that in the plasma by virtue of the fact that the V ISF is much greater than that of the plasma. Third, the term G has an additional independent effect on the [Na ϩ ] pw because it is also a determinant of the magnitude of the y-intercept. This is not surprising because the components of the y-intercept must be similarly affected by the Gibbs-Donnan effect. Specifically, the distribution of non-Na ϩ cations and anions between the plasma and ISF, as represented by the terms osmol ECF , plasma water K ϩ , and osmol pw , will also be altered by the presence of negatively charged, impermeant plasma proteins. Finally, due to Gibbs-Donnan equilibrium, the total osmolar concentration is slightly greater in the protein-containing plasma compartment; this extra osmotic force from diffusible ions is added to the osmotic forces exerted by the plasma anionic proteins (30, 31) . The end result of the Gibbs-Donnan effect is that more water moves into the protein-containing plasma compartment than would be predicted on the basis of the protein concentration alone (30, 31) .
DETERMINANTS OF THE Y-INTERCEPT IN THE EDELMAN EQUATION
There are several physiologically relevant parameters determining the magnitude of the y-intercept which independently modulate the [Na ϩ ] pw : 1) osmotically inactive Na e and K e ; 2) [K ϩ ] pw ; 3) intracellular and extracellular osmotically active non-Na ϩ and non-K ϩ osmoles; and 4) plasma osmotically active non-Na ϩ and non-K ϩ osmoles (27, 28) . We now address the role of each of these parameters in modulating the [Na ϩ ] pw .
(Na osm inactive ϩ K osm inactive )/TBW
There is convincing evidence for the existence of an osmotically inactive Na ϩ and K ϩ reservoir that does not contribute to the distribution of water between the extracellular and intracellular spaces (6, 7, 12-14, 19, 33-35) . It has been shown that Na e in bone and a portion of intracellular K ϩ are bound and are, therefore, osmotically inactive (7, (12) (13) (14) . Similarly, in the syndrome of inappropriate antidiuretic hormone secretion (SIADH), the quantities of Na ϩ lost and H 2 O retained are insufficient to account for the magnitude of the observed reduction in [Na ϩ ] pw in severely hyponatremic patients (6, 33) . This discrepancy has been attributed to loss or inactivation of osmotically active solute. The mechanism of the inactivation of osmotically active solute is unclear. However, it is known that the osmotic inactivation of Na e in SIADH is reversible (29) . Indeed, Nolph and Schrier (29) In the setting of hyperglycemia, changes in the [Na ϩ ] p result not only from the dilutional effect of hyperglycemia induced by the translocation of water but also to changes in the mass balance of Na ϩ , K ϩ , and TBW. Previously, it has been shown that there is an expected decrease of 1.6 meq/l in the plasma [Na ϩ ] for each 100 mg/dl increment in the plasma glucose concentration, assuming no change in the mass balance of Na ϩ , K ϩ , and H 2 O (20) . To predict the effect of changes in the Na e , K e , and TBW as well as the dilutional effect of hyperglycemia on the plasma Na ϩ concentration ([Na ϩ ] p ) attributable to the osmotic shift of water, the [Na ϩ ] p can be predicted from the following equation (27):
Therefore, the y-intercept is not constant in hyperglycemiainduced dilutional hyponatremia resulting from the translocation of water and will vary directly with the plasma glucose concentration (27) (Fig. 3) . The y-intercept changes due to simultaneous alterations in three of the four physiological parameters. First, hyperglycemia results in an increase in the ratio (osmol ECF ϩ osmol ICF )/TBW, which accounts for the hyperglycemia-induced increase in total body osmolality. This ratio increases because hyperglycemia increases the osmol ECF term, whereas the TBW remains unchanged. In the hyperglycemia-induced osmotic shift of water from the intracellular compartment to the extracellular space, the TBW remains constant because the change in intracellular volume (⌬V ICF ) is equal to the change in extracellular volume (⌬V ECF ). Second, the [K ϩ ] pw will also be affected by the hyperglycemia-induced osmotic shift of water as well as the magnitude of subsequent cellular K ϩ efflux induced by the decrease in [K ϩ ] pw and hyperosmolality. Finally, the plasma water concentration of osmotically active non-Na ϩ and non-K ϩ osmoles represented by the term osmol pw /V pw increases in hyperglycemia, thereby lowering the [Na ϩ ] pw by promoting the osmotic movement of water into the plasma space.
In addition to the differential effects of K ϩ on the [Na ϩ ] pw discussed earlier, previous studies have invoked a role for direct cellular Na ϩ uptake (to replace intracellular K ϩ ) as a mechanism for the modulation of [Na ϩ ] pw during hypokalemia resulting from negative K ϩ balance (15, 16, 23) . Indeed, the concept that a deficit of intracellular K ϩ may result in the entry of Na ϩ into cells to restore electroneutrality is supported by the finding of an increase in non-extracellular Na ϩ and increased ratio of non-extracellular Na ϩ to Na e in patients with diureticinduced hyponatremia (15) . However, the cellular uptake of extracellular Na ϩ per se cannot be responsible for the depression of the [Na ϩ ] pw in patients with hypokalemia due to the negative mass balance of K ϩ (26) . The cellular uptake of extracellular Na ϩ without concomitant K ϩ exit will not result in a fall in the [Na ϩ ] pw because osmotic equilibrium must be restored by a shift of extracellular water into the cells, thereby raising the [Na ϩ ] pw to normal. This is demonstrated quantitatively by the fact that the cellular uptake of extracellular Na ϩ without concomitant cellular K ϩ efflux will not change the ratio (Na e ϩ K e )/TBW or any other terms in Eq. 2. In fact, from the standpoint of the [Na ϩ ] pw , it is irrelevant whether Na ϩ is restricted to the intracellular or extracellular compartments. Intracellular Na ϩ , which is as osmotically active as ϩ loss results from cellular K ϩ loss accompanied by cellular anion loss, the nature of the anion will determine whether there will also be a reduction in the (osmol ECF ϩ osmol ICF )/TBW term due to a decrease in the quantity of osmotically active, intracellular non-Na ϩ and non-K ϩ osmoles (osmol ICF ). As previously discussed, the majority of K ϩ loss originates from the ICF because the quantity of exchangeable K ϩ in the ICF, ISF, and plasma space in an average 70-kg man is 3,750 mmol (150 mmol/l ϫ 25 liters), 62 mmol (4.4 mmol/l ϫ 14 liters), and 14 mmol (4.6 mmol/l ϫ 3 liters), respectively. Therefore, K ϩ is lost from the cells along with an intracellular anion from the ICF to the ECF and subsequently is excreted in the urine. For instance, for each millimole of cellular K ϩ loss along with intracellular phosphate in the urine, the net loss is only 1 mmol from the ICF (1 mmol of K ϩ ) because phosphate is derived from an intracellular macromolecule such as RNA (24) . Therefore, there will be no change in the (osmol ECF ϩ osmol ICF )/TBW term in this setting. On the other hand, the loss of cellular K ϩ along with intracellular Cl Ϫ (31) in the urine will result in a net loss of 2 mmol from the ICF (1 mmol of K ϩ and 1 mmol of Cl Ϫ ) and a decrease in the osmol ICF term. Hence, the mechanisms by which K ϩ is lost from the cells will determine the magnitude of change in the [Na ϩ ] pw (26) . In other words, the magnitude of the reduction in the quantity of osmotically active, intracellular non-Na ϩ and non-K ϩ osmoles (osmol ICF ) will determine the magnitude of the decrease in the [Na ϩ ] pw due to the shift of water out of the cells.
Negative ECF K ϩ balance is typically accompanied by negative Cl Ϫ balance. Cl Ϫ anions accompanying interstitial and plasma K ϩ loss will lead to a reduction in the (osmol ECF ϩ osmol ICF )/TBW term due to a decrease in the quantity of osmotically active, extracellular non-Na ϩ and non-K ϩ osmoles (osmol ECF ). The effect of interstitial anion loss on the [Na ϩ ] pw differs from that of plasma anion loss. The loss of anions from the ISF will induce the movement of water from the interstitial space into the plasma space, thereby lowering the [Na ϩ ] pw . On the other hand, plasma anion loss will raise the [Na ϩ ] pw because there are fewer osmotically active, plasma non-Na ϩ osmoles diluting the [Na ϩ ] pw . Because only one-fifth of the ECF is confined to the plasma space (31), quantitatively the loss of interstitial and plasma anions (osmol ECF ) accompanying extracellular K ϩ loss will result in a net decrement in the [Na ϩ ] pw .
LESSONS LEARNED FROM THE EDELMAN EQUATION IN ANALYZING THE GENERATION OF THE DYSNATREMIAS
In analyzing the mechanisms responsible for the generation of the dysnatremias, various approaches have been reported, including measurements of plasma and urine osmolality, free water clearance (FWC), electrolyte free water clearance (EFWC), and tonicity balance (8, 24, 31, 32) . Comparison of the urinary to plasma osmolality is frequently performed in patients with dysnatremias to determine whether the kidney is excreting dilute or concentrated urine (31, 32) . However, such an analysis fails to account for both the input and non-urinary output of H 2 O, Na ϩ , and K ϩ , and it cannot quantitatively predict the magnitude of the change in [Na ϩ ] pw in a given patient (21) . Moreover, urea, which is an ineffective osmole, is included in the osmolality measurement of urine and blood. The FWC and EFWC analyses suffer from similar difficulties in that one cannot accurately and quantitatively predict the magnitude of the expected change in [Na ϩ ] pw as well (21) . It has been suggested that the EFWC analysis is superior to the calculation of FWC to document the role of the kidney in generating the dysnatremias, because the EFWC takes into consideration the fact that urea is an ineffective osmole. However, the EFWC is erroneous in its prediction of the direction of change in the [ (28) . By ignoring the y-intercept, the tonicity balance approach also cannot simultaneously and quantitatively incorporate the role of hyperglycemia in its conceptual framework (21) . Finally, the tonicity balance approach considers the mass balance of electrolytes and water separately. However, patients usually have simultaneous changes in these parameters, necessitating both mathematically and conceptually a single formula that incorporates both the mass balance of Na ϩ ϩ K ϩ (E MB ), and the mass balance of H 2 O (V MB ), as well as the dilutional effect of hyperglycemia on the [Na ϩ ] pw . This is particularly important in analyzing the generation of hyponatremia in patients with ketoacidosis who have simultaneous changes in the mass balance of Na 
In patients with euglycemia, Eq. 3 can be simplified as follows (21) The application of Eq. 3 (or Eq. 3A) provides important clinical insights into the pathogenesis of the dysnatremias and clears up common misconceptions. Historically, hypovolemic hyponatremia was considered a disorder of positive water balance rather than a disorder of Na ϩ ϩ K ϩ imbalance. In contrast to the common misconception that the hyponatremia in patients with volume depletion is generated because of positive water balance due to a decrease in free water excretion, these patients tend to have an E MB (mass balance of Na ϩ ϩ K ϩ ) that is negative and is therefore the primary cause of the hyponatremia (21) . The V MB (mass balance of H 2 O) is also typically negative as expected from the weight loss normally observed in these patients. Therefore, in hypovolemic hyponatremic patients, the negative V MB is contributing to the correction of the hyponatremia but is not of sufficient magnitude to prevent a decrease in the [Na ϩ ] p . In other words, because patients with hypovolemic hyponatremia typically have a decrease in TBW (rather than a gain in TBW), hypovolemic hyponatremia is therefore a disorder of negative Na ϩ and K ϩ balance and inadequate negative H 2 O balance (rather than a disorder of positive H 2 O balance). The negative V MB is inadequate to correct the hyponatremia in these patients due to a defect in urinary water excretion (Table 1) .
On the other hand, in euvolemic hyponatremia, the positive V MB is the cause of the decrease in [Na ϩ ] p , whereas the E MB is negligible in this setting. Similarly, in hypervolemic hyponatremia, the positive V MB is the cause of the hyponatremia. However, in this setting, the positive E MB would tend to raise the [Na ϩ ] p , but its incremental effect is less than the depressive effect of the positive V MB on the [Na ϩ ] p . This type of analysis can also be applied to derive insights into the mechanisms underlying the generation of hypernatremia. In hypovolemic hypernatremia, the negative V MB is the cause of the hypernatremia, whereas the negative E MB in this setting would lower the [Na ϩ ] p but its depressive effect is less than the incremental effect of the negative V MB on the [Na ϩ ] p (Table 2) . In these patients, a defect in thirst mechanism or inadequate access to H 2 O contributes to the negative V MB . In euvolemic hypernatremia, the negative V MB is also the cause of the hypernatremia, but the E MB is negligible in these patients. Finally, in hypervolemic hypernatremia, it is the positive E MB that is the cause of the hypernatremia (rather than negative V MB ); the positive V MB in these patients tends to lower the [Na ϩ ] p but is not of sufficient magnitude to prevent the [Na ϩ ] p from increasing. In this setting, the positive V MB is inadequate to correct the hypernatremia due to a defect in thirst mechanism or inadequate access to H 2 O. (1, 5, 31 ). Several limitations are inherent in these previous formulas used to predict the effect of a given infusate on the change in [Na ϩ ] p (⌬[Na ϩ ] p ). For instance, the limitations inherent in the Na ϩ deficit equation include the lack of consideration of 1) changes in TBW with therapy; 2) the effect of K ϩ on the [Na ϩ ] p ; 3) various sources of Na ϩ , K ϩ , and H 2 O input that the patient may be receiving in addition to the chosen infusate; 4) any ongoing urinary, gastrointestinal, and cutaneous losses of water and electrolytes; and 5) the known empirical relationship between the [Na ϩ ] pw , Na e , K e , and TBW (Eq. 1). Similarly, the water (5) recently proposed a formula that accounts for ongoing renal and extrarenal fluid and electrolyte losses. However, as with the Na ϩ deficit, water deficit, and Androgue-Madias equations, there are several limitations inherent in this equation as well (25) . First, the equation fails to account for other sources of electrolyte and water input (oral intake, total parenteral nutrition, and tube feeding) that may also be contributing to the ⌬[Na ϩ ] p . Second, the BarsoumLevine equation wrongly assumes that [Na ϩ ] p is exactly equal to the ratio (Na e ϩ K e )/TBW. Rather, Edelman et al. (14) empirically demonstrated that the [Na ϩ ] pw (as opposed to [Na ϩ ] p ) is equal to 1.11( Na e ϩ K e )/TBW Ϫ 25.6. Like all previous formulas, the Barsoum-Levine equation fails to consider the fact that plasma is 93% water (2, 9) , and it cannot account for the quantitative and physiological significance of the slope (1.11) and y-intercept (Ϫ25.6) in Eq. 1.
THERAPEUTIC CONSIDERATIONS AND THE ROLE OF Na

CONSEQUENCES OF ASSUMING [Na
Because previous formulas (Na ϩ deficit equation, water deficit equation, Androgue-Madias equation, and BarsoumLevine equation) assume that the [Na ϩ ] p is exactly equal to the ratio (Na e ϩ K e )/TBW, these formulas also wrongly equate the patient's Na e ϩ K e to the product of the [Na ϩ ] p and TBW. Implicitly, these formulas assume that the slope in the Edelman equation is equal to one and that the y-intercept is zero (Fig. 1) . With the quantitative and physiological significance of the slope and y-intercept in Eq. 1 taken into consideration, the initial Na e ϩ K e can be determined as follows (27) The Nguyen-Kurtz formula has recently been derived to accurately determine the amount of a given infusate required to induce a given change in the [Na ϩ ] p (25) : 
In the derivation of this formula, consideration was given to all the inherent assumptions and limitations of the previous formulas. This formula has several advantages: 1) it accounts for all input and output sources of Na ϩ , K ϩ , and H 2 O (mass balance) that can result in a ⌬[Na ϩ ] p ; 2) it takes into consideration the fact that plasma is 93% water (2, 9) and that the [Na ϩ ] pw ϭ 1.11(Na e ϩ K e )/TBW Ϫ 25.6 (Eq. 1); 3) it considers the therapy-induced change in TBW; 4) it is applicable for both hyponatremia and hypernatremia; 5) it calculates directly the amount of the infusate necessary to induce a given ⌬[Na ϩ ] p ; and 6) it may also be used to determine the inappropriateness of the selected fluid prescription in a given clinical situation (25) .
In the setting of hyperglycemia, none of the previous formulas is applicable. Recently, we demonstrated that an elevation in blood glucose lowers the [Na ϩ ] p because it increases the magnitude of the y-intercept in Eq. 1 in a predictable fashion by increasing the concentration of osmotically active non-Na ϩ and non-K ϩ osmoles (21, 27, 28) . Accordingly, the y-intercept of 23.8 in the Nguyen-Kurtz formula needs to be replaced by the specific hyperglycemia-modified value in patients with hyperglycemia. During stable hyperglycemia, the Nguyen-Kurtz formula incorporating the modified y-intercept can be used as a guide to therapy. Although the glucose-induced change in the magnitude of the y-intercept can be determined retrospectively and therefore used in a straightforward manner to quantitatively analyze the generation of the dysnatremias (21) , it is impossible to prospectively predict the blood glucose level in any patient. Therefore, blood chemistries need to be measured more frequently as a guide to therapy in those patients who are predicted clinically to have unstable blood glucose levels.
Similarly, the magnitude of the y-intercept in the Edelman equation can theoretically change when there is a major change in any of the other components of the y-intercept. For instance, the y-intercept may potentially change if there is a significant change in the quantity of osmotically inactive Na e and K e or intracellular osmotically active, non-Na ϩ and non-K ϩ osmoles. Unfortunately, it is currently not clinically feasible for one to account for these factors prospectively. Moreover, as with all previous formulas, it is important to realize that there may be dynamic changes in the mass balance of Na ϩ , K (33) . Since its first description, the pathogenesis and management of this disorder have been well characterized. The primary factor in the pathogenesis of the hyponatremia in SIADH is thought to be water retention rather than cation loss (29) . Indeed, Nolph and Schrier (29) demonstrated that the increase in urinary Na ϩ excretion seen with rapid water expansion in SIADH is associated with a reciprocal depression in urinary K ϩ excretion. As a result, the negative Na ϩ balance occurring during the rapid increase in TBW is offset by the positive K ϩ balance such that the net cumulative loss of Na e and K e is negligible in SIADH. Because water retention rather than cation loss is the main contributor to the development of hyponatremia in SIADH (29) , therapeutic maneuvers that primarily result in negative water balance rather than positive Na ϩ balance would be the preferred mode of treatment. Until a vasopressin-receptor antagonist is available for clinical use, water restriction is the mainstay of therapy in asymptomatic SIADH. However, severe, symptomatic hyponatremia due to SIADH often requires the administration of intravenous saline.
All the above formulas are not applicable in predicting the ⌬[Na ϩ ] p in severe symptomatic SIADH in clinical situations where intravenous therapy (hypertonic saline Ϯ furosemide) is used to increase the [Na ϩ ] p more rapidly than water restriction alone. These formulas cannot be used to predict the effect of a given infusate on the ⌬[Na ϩ ] p in patients with symptomatic SIADH because they fail to consider the neutral solute balance maintained in these patients (25) . Indeed, Na ϩ handling and therefore volume regulation are intact in patients with SIADH in the steady state (29, 32) . Specifically, in SIADH, solute balance is maintained and the administered Na ϩ and K ϩ are excreted in the urine. Correction of hyponatremia in SIADH, therefore, occurs by attaining negative water balance while maintaining neutral Na ϩ and K ϩ balance. None of the above formulas accounts for the intact Na ϩ handling in SIADH and therefore cannot be utilized in the treatment of this disorder. Consequently, a new formula has recently been derived that is applicable in the treatment of severe symptomatic SIADH requiring intravenous therapy (25) ] pw , Na e , K e , and TBW discovered by Edelman et al. (14) has played a pivotal role in recent theoretical and quantitative considerations that have advanced our understanding of the physiologically relevant parameters that modulate the [Na ϩ ] pw . The non-zero values of the slope and y-intercept in the Edelman equation are a necessary consequence of the effects of the osmotic coefficient (Ø) of Na ϩ salts at physiological concentrations and Gibbs-Donnan and osmotic equilibrium. In addition to Na e , K e , and TBW, the physiological components of the y-intercept in this equation play a role in modulating the [Na ϩ ] pw and in the generation of the dysnatremias. These physiological components that determine the magnitude of the y-intercept and therefore the [Na ϩ ] pw are the osmotically inactive Na e and K e , [K ϩ ] pw , and the osmotically active nonNa ϩ and non-K ϩ osmoles. An appreciation of these parameters is critically important in conceptually understanding the effect of hyperglycemia on the [Na ϩ ] pw and the complex role of K ϩ in modulating the [Na ϩ ] pw . These considerations have recently led to the derivation of new formulas for analyzing the generation and treatment of the dysnatremias that can be tested experimentally.
